Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Beats on EPS, Stock Up 3.59%

Collegium Pharmaceutical reported a narrower-than-expected loss per share, which led to a positive stock reaction, with shares rising 3.59%. The lack of revenue data and management commentary leaves some uncertainty about the company's overall performance and future outlook. Investors may be cautiously optimistic due to the EPS beat, but further details are needed for a complete picture.